Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.2880452688146964e-58,57.466491841491845,7606.244295679198,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.006141852257297e-55,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.350756458598242e-36,26.986181613085165,2228.8534677395437,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.06665738165531e-34,0,0,51
3,Oxidative phosphorylation WP623,1.0566788643437631e-21,25.115864527629235,1213.0750616620342,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.0778124416306383e-19,0,0,30
4,Nonalcoholic fatty liver disease WP4396,3.290358541984529e-20,9.122790697674418,409.25482520005346,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'PPARA']",2.5171242846181647e-18,0,0,42
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.400370985239978e-11,10.648761112161907,256.6836104684865,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",2.0810270429668667e-09,0,0,20
6,Mitochondrial CIV Assembly WP4922,1.4374496107378484e-09,13.485645933014354,274.5730833837743,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'COX20']",7.330993014763027e-08,0,0,15
7,Mitochondrial complex III assembly WP4921,0.0005955325915289389,8.869496855345911,65.8653665118906,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.02603328185826504,0,0,6
8,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0029260639126254258,11.795193312434693,68.81430349457165,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.11192194465792253,0,0,4
9,Translation Factors WP107,0.00693228194396868,3.380501727504882,16.80638824629137,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.23569758609493513,0,0,8
10,Cellular Proteostasis WP4918,0.016723196451488783,8.832550860719875,36.13359914637577,"['VBP1', 'PFDN4', 'PFDN6']",0.5117298114155567,0,0,3
11,Glycolysis in senescence WP5049,0.02707107084994458,6.623239436619718,23.905189333394194,"['LDHA', 'ALDOC', 'HK1']",0.7135899637909825,0,0,3
12,Synaptic Vesicle Pathway WP2267,0.02999057239839154,2.95020964360587,10.346008183613229,"['SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1']",0.7135899637909825,0,0,6
13,Base Excision Repair WP4752,0.030315913494388145,3.4017630720927423,11.89284436760227,"['POLE4', 'NEIL2', 'MPG', 'TDG', 'POLD2']",0.7135899637909825,0,0,5
14,Proteasome Degradation WP183,0.052360748891411825,2.294546515018956,6.767989892613009,"['PSMB6', 'PSMC5', 'PSMB5', 'PSMB3', 'PSMC1', 'HLA-B', 'PSMB10']",0.9910724586638838,0,0,7
15,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.054286235536203334,8.8203125,25.697844401144526,"['GSTP1', 'COX5A']",0.9910724586638838,0,0,2
16,Glutathione metabolism WP100,0.054286235536203334,8.8203125,25.697844401144526,"['GPX4', 'GSS']",0.9910724586638838,0,0,2
17,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.05586267874282597,2.762460753532182,7.969309117892838,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9910724586638838,0,0,5
18,Selenium Micronutrient Network WP15,0.07811466309299357,2.4546485260770976,6.258316633076374,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOH']",0.9910724586638838,0,0,5
19,DNA Repair Pathways Full Network WP4946,0.08245869097843106,1.913206581976298,4.774326338616599,"['POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'MPG', 'TDG', 'POLD2', 'GTF2H5']",0.9910724586638838,0,0,8
20,Glucuronidation WP698,0.10208274858634168,inf,inf,['HK1'],0.9910724586638838,0,0,1
21,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.11606845865429252,2.941053729786124,6.333780083580306,"['MDH2', 'IDH3G', 'IDH3A']",0.9910724586638838,0,0,3
22,Pyrimidine metabolism WP4022,0.11881819104955964,1.819870310328856,3.876616324194113,"['POLE4', 'POLR3GL', 'POLD2', 'ENPP1', 'NME3', 'POLR2I', 'POLR2K']",0.9910724586638838,0,0,7
23,7q11.23 copy number variation syndrome WP4932,0.13225371940642563,1.6839417154874567,3.4066698029406686,"['ATP5F1A', 'ATP5F1B', 'ATP5MC2', 'ATP5PO', 'SQSTM1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.9910724586638838,0,0,8
24,Ferroptosis WP4313,0.14021625585299208,2.2065047021943576,4.3348315383647655,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2']",0.9910724586638838,0,0,4
25,Modulators of TCR signaling and T cell activation WP5072,0.14021625585299208,2.2065047021943576,4.3348315383647655,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9910724586638838,0,0,4
26,Type II diabetes mellitus WP1584,0.15480628947675396,3.52625,6.578503904434907,"['SURF1', 'PRKCD']",0.9910724586638838,0,0,2
27,Nanomaterial induced apoptosis WP2507,0.15480628947675396,3.52625,6.578503904434907,"['ENDOG', 'CYCS']",0.9910724586638838,0,0,2
28,DNA Mismatch Repair WP531,0.19304689944045653,2.9380208333333333,4.832521647799989,"['POLE4', 'POLD2']",0.9910724586638838,0,0,2
29,15q11.2 copy number variation syndrome WP4940,0.19375928710332704,8.80811232449298,14.45533381995379,['TUBGCP4'],0.9910724586638838,0,0,1
30,Small Ligand GPCRs WP247,0.19375928710332704,8.80811232449298,14.45533381995379,['LPAR1'],0.9910724586638838,0,0,1
31,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.19375928710332704,8.80811232449298,14.45533381995379,['VIP'],0.9910724586638838,0,0,1
32,EV release from cardiac cells and their functional effects WP3297,0.19375928710332704,8.80811232449298,14.45533381995379,['ERBB4'],0.9910724586638838,0,0,1
33,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.19375928710332704,8.80811232449298,14.45533381995379,['GSS'],0.9910724586638838,0,0,1
34,Gastric acid production WP2596,0.19375928710332704,8.80811232449298,14.45533381995379,['VIP'],0.9910724586638838,0,0,1
35,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.19375928710332704,8.80811232449298,14.45533381995379,['ELOB'],0.9910724586638838,0,0,1
36,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.19375928710332704,8.80811232449298,14.45533381995379,['BLVRB'],0.9910724586638838,0,0,1
37,let-7 inhibition of ES cell reprogramming WP3299,0.19375928710332704,8.80811232449298,14.45533381995379,['SOX2'],0.9910724586638838,0,0,1
38,"Phase I biotransformations, non P450 WP136",0.19375928710332704,8.80811232449298,14.45533381995379,['CES2'],0.9910724586638838,0,0,1
39,Exercise-induced Circadian Regulation WP410,0.20249434307453923,1.857119287246329,2.965899967479937,"['DAZAP2', 'HSPA8', 'SUMO1', 'GSTP1']",0.9910724586638838,0,0,4
40,Glycolysis and Gluconeogenesis WP534,0.20249434307453923,1.857119287246329,2.965899967479937,"['LDHA', 'MDH2', 'ALDOC', 'HK1']",0.9910724586638838,0,0,4
41,CAMKK2  Pathway WP4874,0.21953402999898403,2.034669555796316,3.0850636941192575,"['FIS1', 'MAP1LC3A', 'SQSTM1']",0.9910724586638838,0,0,3
42,Type II interferon signaling (IFNG) WP619,0.2322973022201485,2.517857142857143,3.6754098681973377,"['PRKCD', 'HLA-B']",0.9910724586638838,0,0,2
43,Computational Model of Aerobic Glycolysis WP4629,0.2322973022201485,2.517857142857143,3.6754098681973377,"['LDHA', 'HK1']",0.9910724586638838,0,0,2
44,Cori Cycle WP1946,0.2322973022201485,2.517857142857143,3.6754098681973377,"['LDHA', 'HK1']",0.9910724586638838,0,0,2
45,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.2322973022201485,2.517857142857143,3.6754098681973377,"['FGF1', 'GTPBP4']",0.9910724586638838,0,0,2
46,Neural Crest Cell Migration during Development WP4564,0.2322973022201485,2.517857142857143,3.6754098681973377,"['CDH11', 'EPHB3']",0.9910724586638838,0,0,2
47,Cell migration and invasion through p75NTR WP4561,0.2719539623040165,2.202734375,2.8682299543081453,"['EFNB2', 'CDH11']",0.9910724586638838,0,0,2
48,Neural Crest Cell Migration in Cancer WP4565,0.2719539623040165,2.202734375,2.8682299543081453,"['CDH11', 'EPHB3']",0.9910724586638838,0,0,2
49,Cytosine methylation WP3585,0.2760888355374766,4.403276131045242,5.667159914969125,['TDG'],0.9910724586638838,0,0,1
50,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.2760888355374766,4.403276131045242,5.667159914969125,['PPARA'],0.9910724586638838,0,0,1
51,Estrogen Receptor Pathway WP2881,0.2760888355374766,4.403276131045242,5.667159914969125,['PPARA'],0.9910724586638838,0,0,1
52,Homologous recombination WP186,0.2760888355374766,4.403276131045242,5.667159914969125,['POLD2'],0.9910724586638838,0,0,1
53,Non-homologous end joining WP438,0.2760888355374766,4.403276131045242,5.667159914969125,['DCLRE1C'],0.9910724586638838,0,0,1
54,GABA receptor Signaling WP4159,0.276629805824717,1.762754303599374,2.265271676537126,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9910724586638838,0,0,3
55,Wnt signaling pathway and pluripotency WP399,0.29494482896470137,1.5330516559901868,1.8718054208440482,"['SOX2', 'PRKCG', 'PRKCD', 'DVL3']",0.9910724586638838,0,0,4
56,mRNA Processing WP411,0.2963704897883547,1.3069283794835844,1.5894143521636217,"['LSM7', 'SF3A1', 'CELF1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'SRSF9']",0.9910724586638838,0,0,8
57,Cytosolic DNA-sensing pathway WP4655,0.3057290051235652,1.6522887323943662,1.9580549628608885,"['IRF3', 'POLR3GL', 'POLR2K']",0.9910724586638838,0,0,3
58,Fluoropyrimidine Activity WP1601,0.311525712393427,1.957638888888889,2.2831421636254445,"['TDG', 'CES2']",0.9910724586638838,0,0,2
59,Nucleotide Excision Repair WP4753,0.3349371328663119,1.5548191107428888,1.7006804663948965,"['POLE4', 'POLD2', 'GTF2H5']",0.9910724586638838,0,0,3
60,ACE Inhibitor Pathway WP554,0.35002302583057193,2.934997399895996,3.08103212424276,['ATP6AP2'],0.9910724586638838,0,0,1
61,Apoptosis Modulation by HSP70 WP384,0.35002302583057193,2.934997399895996,3.08103212424276,['CYCS'],0.9910724586638838,0,0,1
62,Aspirin and miRNAs WP4707,0.35002302583057193,2.934997399895996,3.08103212424276,['PPARA'],0.9910724586638838,0,0,1
63,"Cerebral organic acidurias, including diseases WP4519",0.35002302583057193,2.934997399895996,3.08103212424276,['MDH2'],0.9910724586638838,0,0,1
64,Dopaminergic Neurogenesis WP2855,0.35002302583057193,2.934997399895996,3.08103212424276,['SOX2'],0.9910724586638838,0,0,1
65,Dual hijack model of Vif in HIV infection WP3300,0.35002302583057193,2.934997399895996,3.08103212424276,['ELOB'],0.9910724586638838,0,0,1
66,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.35002302583057193,2.934997399895996,3.08103212424276,['PPARA'],0.9910724586638838,0,0,1
67,Galanin receptor pathway WP4970,0.35002302583057193,2.934997399895996,3.08103212424276,['PRKCD'],0.9910724586638838,0,0,1
68,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.35002302583057193,2.934997399895996,3.08103212424276,['SQSTM1'],0.9910724586638838,0,0,1
69,Irinotecan pathway WP229,0.35002302583057193,2.934997399895996,3.08103212424276,['CES2'],0.9910724586638838,0,0,1
70,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.35002302583057193,2.934997399895996,3.08103212424276,['VEGFB'],0.9910724586638838,0,0,1
71,White fat cell differentiation WP4149,0.35061715636298507,1.7615625,1.846223851516817,"['IRF3', 'DDIT3']",0.9910724586638838,0,0,2
72,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.35061715636298507,1.7615625,1.846223851516817,"['LDHA', 'RPS6']",0.9910724586638838,0,0,2
73,Notch Signaling WP268,0.35061715636298507,1.7615625,1.846223851516817,"['APH1A', 'DVL3']",0.9910724586638838,0,0,2
74,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.35061715636298507,1.7615625,1.846223851516817,"['NDUFA13', 'AAMP']",0.9910724586638838,0,0,2
75,PKC-gamma calcium signaling pathway in ataxia WP4760,0.35061715636298507,1.7615625,1.846223851516817,"['PRKCG', 'TRPC3']",0.9910724586638838,0,0,2
76,Pre-implantation embryo WP3527,0.35061715636298507,1.7615625,1.846223851516817,"['SOX2', 'DDIT3']",0.9910724586638838,0,0,2
77,Metapathway biotransformation Phase I and II WP702,0.3670257897812602,1.295826022716779,1.2988364358602689,"['CYP4Z1', 'GPX4', 'GSTO1', 'GSTP1', 'GSS']",0.9910724586638838,0,0,5
78,Allograft Rejection WP2328,0.3889142823025799,1.6011363636363636,1.51210727942614,"['COL5A1', 'HLA-B']",0.9910724586638838,0,0,2
79,DNA Replication WP466,0.3889142823025799,1.6011363636363636,1.51210727942614,"['POLD2', 'UBA52']",0.9910724586638838,0,0,2
80,SARS-CoV-2 mitochondrial interactions WP5038,0.3889142823025799,1.6011363636363636,1.51210727942614,"['NDUFB9', 'IRF3']",0.9910724586638838,0,0,2
81,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3930120132473246,1.3906597479614529,1.2987581369168786,"['OTUD5', 'IRF3', 'PIN1']",0.9910724586638838,0,0,3
82,Ciliary landscape WP4352,0.4036987147961814,1.1272435779309329,1.0225073581324688,"['MYL6', 'NDUFA5', 'WNK1', 'SSNA1', 'DVL3', 'COPS7A', 'MYL6B', 'SNRPB2', 'COX6C', 'DCAF11', 'LSM4']",0.9910724586638838,0,0,11
83,Alzheimer's disease WP2059,0.41544982745745984,1.2581728616211374,1.1051707681373504,"['ATP5MD', 'APH1A', 'CHP1', 'CYCS']",0.9910724586638838,0,0,4
84,Amino Acid metabolism WP3925,0.41544982745745984,1.2581728616211374,1.1051707681373504,"['LDHA', 'MDH2', 'GSS', 'ODC1']",0.9910724586638838,0,0,4
85,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.41641675082873447,2.200858034321373,1.9281028707202148,['IRF3'],0.9910724586638838,0,0,1
86,Transcriptional cascade regulating adipogenesis WP4211,0.41641675082873447,2.200858034321373,1.9281028707202148,['DDIT3'],0.9910724586638838,0,0,1
87,Genes targeted by miRNAs in adipocytes WP1992,0.41641675082873447,2.200858034321373,1.9281028707202148,['TMSB4X'],0.9910724586638838,0,0,1
88,Insulin signaling in adipocytes (diabetic condition) WP3635,0.41641675082873447,2.200858034321373,1.9281028707202148,['RPS6'],0.9910724586638838,0,0,1
89,Insulin signaling in adipocytes (normal condition) WP3634,0.41641675082873447,2.200858034321373,1.9281028707202148,['RPS6'],0.9910724586638838,0,0,1
90,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.41641675082873447,2.200858034321373,1.9281028707202148,['ERBB4'],0.9910724586638838,0,0,1
91,Matrix Metalloproteinases WP129,0.41641675082873447,2.200858034321373,1.9281028707202148,['MMP16'],0.9910724586638838,0,0,1
92,miR-509-3p alteration of YAP1/ECM axis WP3967,0.41641675082873447,2.200858034321373,1.9281028707202148,['COL5A1'],0.9910724586638838,0,0,1
93,Mitochondrial fatty acid synthesis pathway WP4317,0.41641675082873447,2.200858034321373,1.9281028707202148,['HSD17B12'],0.9910724586638838,0,0,1
94,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.41641675082873447,2.200858034321373,1.9281028707202148,['IRF3'],0.9910724586638838,0,0,1
95,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.42158965443395047,1.3208920187793427,1.1408845805313268,"['PRKCG', 'IFI27L2', 'PRKCD']",0.9910724586638838,0,0,3
96,Unfolded protein response WP4925,0.42617200737247174,1.4674479166666667,1.2516042912024972,"['DDIT3', 'EIF2S1']",0.9910724586638838,0,0,2
97,Complement system WP2806,0.42617200737247174,1.4674479166666667,1.2516042912024972,"['RPS19', 'CD59']",0.9910724586638838,0,0,2
98,IL-18 signaling pathway WP4754,0.4620326368471077,1.0856326689605922,0.8382384226364807,"['TOMM40', 'GRM7', 'CD81', 'NACA', 'TMSB4X', 'PRKCD', 'CYCS', 'NDUFC1', 'RND2']",0.9910724586638838,0,0,9
99,MAPK Signaling Pathway WP382,0.4620326368471077,1.0856326689605922,0.8382384226364807,"['PRKCG', 'DUSP4', 'HSPA8', 'DUSP3', 'DDIT3', 'PRKCD', 'FGF1', 'RASGRP2', 'NGF']",0.9910724586638838,0,0,9
100,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4622034124084294,1.354326923076923,1.0452020713118997,"['PRKCG', 'PRKCD']",0.9910724586638838,0,0,2
101,Parkinson's disease pathway WP2371,0.4622034124084294,1.354326923076923,1.0452020713118997,"['CYCS', 'PARK7']",0.9910724586638838,0,0,2
102,Serotonin and anxiety-related events WP3944,0.4760379748160547,1.760374414976599,1.306651374457568,['CRH'],0.9910724586638838,0,0,1
103,Thiamine metabolic pathways WP4297,0.4760379748160547,1.760374414976599,1.306651374457568,['BCKDK'],0.9910724586638838,0,0,1
104,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.4760379748160547,1.760374414976599,1.306651374457568,['ENPP1'],0.9910724586638838,0,0,1
105,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4760379748160547,1.760374414976599,1.306651374457568,['GRM7'],0.9910724586638838,0,0,1
106,Heart Development WP1591,0.4760379748160547,1.760374414976599,1.306651374457568,['VEGFB'],0.9910724586638838,0,0,1
107,HIF1A and PPARG regulation of glycolysis WP2456,0.4760379748160547,1.760374414976599,1.306651374457568,['LDHA'],0.9910724586638838,0,0,1
108,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.4760379748160547,1.760374414976599,1.306651374457568,['MAP1LC3A'],0.9910724586638838,0,0,1
109,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4760379748160547,1.760374414976599,1.306651374457568,['ERBB4'],0.9910724586638838,0,0,1
110,Nanoparticle triggered autophagic cell death WP2509,0.4760379748160547,1.760374414976599,1.306651374457568,['MAP1LC3A'],0.9910724586638838,0,0,1
111,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.4760379748160547,1.760374414976599,1.306651374457568,['LDHA'],0.9910724586638838,0,0,1
112,PPAR-alpha pathway WP2878,0.4760379748160547,1.760374414976599,1.306651374457568,['PPARA'],0.9910724586638838,0,0,1
113,Eukaryotic Transcription Initiation WP405,0.4772323299217835,1.2003841229193342,0.8879863658520618,"['TAF13', 'POLR2I', 'POLR2K']",0.9910724586638838,0,0,3
114,Metabolic reprogramming in colon cancer WP4290,0.4772323299217835,1.2003841229193342,0.8879863658520618,"['LDHA', 'MDH2', 'IDH3A']",0.9910724586638838,0,0,3
115,Glycogen Synthesis and Degradation WP500,0.4968704502372822,1.2573660714285715,0.8794344594727007,"['PHKG1', 'HK1']",0.9910724586638838,0,0,2
116,Histone Modifications WP2369,0.4968704502372822,1.2573660714285715,0.8794344594727007,"['SET', 'SETDB2']",0.9910724586638838,0,0,2
117,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5138080910748671,1.0153476331360947,0.6761255194146479,"['RPL5', 'SET', 'TRPC3', 'PRKCD', 'RPS6', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'CCT7', 'EIF3D', 'PTMA']",0.9910724586638838,0,0,18
118,Signal Transduction of S1P Receptor WP26,0.5295765586920959,1.46671866874675,0.932360111740898,['ASAH1'],0.9910724586638838,0,0,1
119,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5295765586920959,1.46671866874675,0.932360111740898,['SST'],0.9910724586638838,0,0,1
120,Cell Differentiation - Index expanded WP2023,0.5295765586920959,1.46671866874675,0.932360111740898,['SOX2'],0.9910724586638838,0,0,1
121,Urea cycle and associated pathways WP4595,0.5295765586920959,1.46671866874675,0.932360111740898,['MDH2'],0.9910724586638838,0,0,1
122,Urea cycle and metabolism of amino groups WP497,0.5295765586920959,1.46671866874675,0.932360111740898,['ODC1'],0.9910724586638838,0,0,1
123,Wnt signaling in kidney disease WP4150,0.5295765586920959,1.46671866874675,0.932360111740898,['DVL3'],0.9910724586638838,0,0,1
124,Cysteine and methionine catabolism WP4504,0.5295765586920959,1.46671866874675,0.932360111740898,['GSS'],0.9910724586638838,0,0,1
125,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5295765586920959,1.46671866874675,0.932360111740898,['CD81'],0.9910724586638838,0,0,1
126,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5295765586920959,1.46671866874675,0.932360111740898,['EIF2AK1'],0.9910724586638838,0,0,1
127,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5295765586920959,1.46671866874675,0.932360111740898,['MDH2'],0.9910724586638838,0,0,1
128,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.5295765586920959,1.46671866874675,0.932360111740898,['PPARA'],0.9910724586638838,0,0,1
129,SARS coronavirus and innate immunity WP4912,0.5295765586920959,1.46671866874675,0.932360111740898,['IRF3'],0.9910724586638838,0,0,1
130,Acute viral myocarditis WP4298,0.5556099213955215,1.055774647887324,0.6204669476887859,"['ENDOG', 'CYCS', 'DMD']",0.9910724586638838,0,0,3
131,Wnt Signaling Pathway WP363,0.5617566879022342,1.0998046875,0.6342424746858794,"['PRKCG', 'DVL3']",0.9910724586638838,0,0,2
132,Genotoxicity pathway WP4286,0.5617566879022342,1.0998046875,0.6342424746858794,"['RPS27', 'PHLDA3']",0.9910724586638838,0,0,2
133,IL-6 signaling pathway WP364,0.5617566879022342,1.0998046875,0.6342424746858794,"['PRKCD', 'VIP']",0.9910724586638838,0,0,2
134,One-carbon metabolism and related pathways WP3940,0.5617566879022342,1.0998046875,0.6342424746858794,"['GPX4', 'GSS']",0.9910724586638838,0,0,2
135,Regulation of toll-like receptor signaling pathway WP1449,0.5738384490121571,1.0052843708016121,0.5583423484794011,"['OTUD5', 'IRF3', 'SQSTM1', 'RNF41']",0.9910724586638838,0,0,4
136,Sleep regulation WP3591,0.5776521915167182,1.2569645642968577,0.6898012070945612,['CRH'],0.9910724586638838,0,0,1
137,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5776521915167182,1.2569645642968577,0.6898012070945612,['IRF3'],0.9910724586638838,0,0,1
138,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5776521915167182,1.2569645642968577,0.6898012070945612,['B3GALT2'],0.9910724586638838,0,0,1
139,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5776521915167182,1.2569645642968577,0.6898012070945612,['SHISA5'],0.9910724586638838,0,0,1
140,Development of ureteric collection system WP5053,0.5918775705622933,1.0349264705882353,0.5427728505846883,"['ROBO2', 'GDF11']",0.9910724586638838,0,0,2
141,Energy Metabolism WP1541,0.5918775705622933,1.0349264705882353,0.5427728505846883,"['PPRC1', 'PPARA']",0.9910724586638838,0,0,2
142,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5918775705622933,1.0349264705882353,0.5427728505846883,"['LDHA', 'HK1']",0.9910724586638838,0,0,2
143,Pathways in clear cell renal cell carcinoma WP4018,0.5944719058921927,0.9771856495994427,0.5082164917736922,"['LDHA', 'ALDOC', 'SQSTM1', 'HK1']",0.9910724586638838,0,0,4
144,Regulation of Microtubule Cytoskeleton WP2038,0.6204264858719815,0.9772569444444444,0.4664918013319618,"['PARD6A', 'MAPRE1']",0.9910724586638838,0,0,2
145,Serotonin and anxiety WP3947,0.6208215181992685,1.0996489859594383,0.5242154810506764,['CRH'],0.9910724586638838,0,0,1
146,Sphingolipid Metabolism (general overview) WP4725,0.6208215181992685,1.0996489859594383,0.5242154810506764,['ASAH1'],0.9910724586638838,0,0,1
147,Sphingolipid Metabolism (integrated pathway) WP4726,0.6208215181992685,1.0996489859594383,0.5242154810506764,['ASAH1'],0.9910724586638838,0,0,1
148,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.6208215181992685,1.0996489859594383,0.5242154810506764,['PPARA'],0.9910724586638838,0,0,1
149,Striated Muscle Contraction Pathway WP383,0.6208215181992685,1.0996489859594383,0.5242154810506764,['DMD'],0.9910724586638838,0,0,1
150,Toll-like Receptor Signaling related to MyD88 WP3858,0.6208215181992685,1.0996489859594383,0.5242154810506764,['IRF3'],0.9910724586638838,0,0,1
151,Zinc homeostasis WP3529,0.6208215181992685,1.0996489859594383,0.5242154810506764,['SLC30A3'],0.9910724586638838,0,0,1
152,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6208215181992685,1.0996489859594383,0.5242154810506764,['CYCS'],0.9910724586638838,0,0,1
153,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6208215181992685,1.0996489859594383,0.5242154810506764,['RPS6'],0.9910724586638838,0,0,1
154,Hippo-Yap signaling pathway WP4537,0.6208215181992685,1.0996489859594383,0.5242154810506764,['TNIK'],0.9910724586638838,0,0,1
155,miRNA targets in ECM and membrane receptors WP2911,0.6208215181992685,1.0996489859594383,0.5242154810506764,['COL5A1'],0.9910724586638838,0,0,1
156,Mitochondrial Gene Expression WP391,0.6208215181992685,1.0996489859594383,0.5242154810506764,['PPRC1'],0.9910724586638838,0,0,1
157,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6208215181992685,1.0996489859594383,0.5242154810506764,['OMG'],0.9910724586638838,0,0,1
158,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6208215181992685,1.0996489859594383,0.5242154810506764,['GSTP1'],0.9910724586638838,0,0,1
159,Pregnane X receptor pathway WP2876,0.6208215181992685,1.0996489859594383,0.5242154810506764,['PSMC5'],0.9910724586638838,0,0,1
160,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6265260883480991,0.9421529175050302,0.4405176008303593,"['PRKCG', 'RPS6', 'PDGFC']",0.9910724586638838,0,0,3
161,MECP2 and Associated Rett Syndrome WP3584,0.6265260883480991,0.9421529175050302,0.4405176008303593,"['BCL6', 'SST', 'RPS6']",0.9910724586638838,0,0,3
162,EGF/EGFR signaling pathway WP437,0.6414588655414215,0.9155873888016746,0.4065301572784682,"['NDUFA13', 'PRKCD', 'AP2S1', 'NEDD8', 'AP2M1']",0.9910724586638838,0,0,5
163,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6581146585591603,0.8967417422227918,0.3751753215236857,"['RPS6', 'PRKCD', 'NGF', 'SQSTM1', 'EIF2S1']",0.9910724586638838,0,0,5
164,16p11.2 distal deletion syndrome WP4950,0.6595845443047514,0.9772924250303345,0.4066954739706199,['CD81'],0.9910724586638838,0,0,1
165,Alpha 6 Beta 4 signaling pathway WP244,0.6595845443047514,0.9772924250303345,0.4066954739706199,['PRKCD'],0.9910724586638838,0,0,1
166,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6595845443047514,0.9772924250303345,0.4066954739706199,['RPS6'],0.9910724586638838,0,0,1
167,TLR4 Signaling and Tolerance WP3851,0.6595845443047514,0.9772924250303345,0.4066954739706199,['IRF3'],0.9910724586638838,0,0,1
168,TP53 network WP1742,0.6595845443047514,0.9772924250303345,0.4066954739706199,['SUMO1'],0.9910724586638838,0,0,1
169,GDNF/RET signaling axis WP4830,0.6595845443047514,0.9772924250303345,0.4066954739706199,['ROBO2'],0.9910724586638838,0,0,1
170,MTHFR deficiency WP4288,0.6595845443047514,0.9772924250303345,0.4066954739706199,['CYCS'],0.9910724586638838,0,0,1
171,NOTCH1 regulation of endothelial cell calcification WP3413,0.6595845443047514,0.9772924250303345,0.4066954739706199,['LPAR1'],0.9910724586638838,0,0,1
172,Oxidation by Cytochrome P450 WP43,0.6595845443047514,0.9772924250303345,0.4066954739706199,['CYP4Z1'],0.9910724586638838,0,0,1
173,B Cell Receptor Signaling Pathway WP23,0.6692740746623221,0.8790297339593114,0.3529846080659111,"['BCL6', 'CD81', 'PRKCD']",0.9910724586638838,0,0,3
174,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6728498047497323,0.87921875,0.34837561219506824,"['ERBB4', 'TMSB4X']",0.9910724586638838,0,0,2
175,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6728498047497323,0.87921875,0.34837561219506824,"['PRKCD', 'RPS6']",0.9910724586638838,0,0,2
176,Adipogenesis WP236,0.6882242769693273,0.8572520834926217,0.3203041058487483,"['CELF1', 'DDIT3', 'PPARA', 'ZMPSTE24']",0.9910724586638838,0,0,4
177,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6892619416535815,0.8505224897773739,0.3165082542645429,"['HSPA8', 'PSMC5', 'PSMC1']",0.9910724586638838,0,0,3
178,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6943903909079201,0.8794071762870515,0.32073822403480334,['IDH3A'],0.9910724586638838,0,0,1
179,BDNF-TrkB Signaling WP3676,0.6943903909079201,0.8794071762870515,0.32073822403480334,['TRPC3'],0.9910724586638838,0,0,1
180,Trans-sulfuration and one-carbon metabolism WP2525,0.6943903909079201,0.8794071762870515,0.32073822403480334,['GSS'],0.9910724586638838,0,0,1
181,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6943903909079201,0.8794071762870515,0.32073822403480334,['BCL6'],0.9910724586638838,0,0,1
182,Methionine De Novo and Salvage Pathway WP3580,0.6943903909079201,0.8794071762870515,0.32073822403480334,['ODC1'],0.9910724586638838,0,0,1
183,Nanoparticle-mediated activation of receptor signaling WP2643,0.6943903909079201,0.8794071762870515,0.32073822403480334,['TLN1'],0.9910724586638838,0,0,1
184,NRF2 pathway WP2884,0.7050090469513072,0.8366920435885953,0.29246122226042365,"['GSTP1', 'BLVRB', 'SQSTM1', 'CES2']",0.9910724586638838,0,0,4
185,16p11.2 proximal deletion syndrome WP4949,0.7083295021772489,0.8237969483568075,0.28408299595214725,"['TMEM219', 'SEZ6L2', 'CCT7']",0.9910724586638838,0,0,3
186,AGE/RAGE pathway WP2324,0.7192413122240942,0.7990056818181818,0.26331899858396124,"['PRKCD', 'CYCS']",0.9910724586638838,0,0,2
187,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7192413122240942,0.7990056818181818,0.26331899858396124,"['RNF7', 'SQSTM1']",0.9910724586638838,0,0,2
188,Sphingolipid pathway WP1422,0.7256424657818636,0.7993192454970927,0.25633996895871763,['ASAH1'],0.9910724586638838,0,0,1
189,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7256424657818636,0.7993192454970927,0.25633996895871763,['IRF3'],0.9910724586638838,0,0,1
190,IL-2 signaling pathway WP49,0.7256424657818636,0.7993192454970927,0.25633996895871763,['RPS6'],0.9910724586638838,0,0,1
191,Osteoblast differentiation WP4787,0.7264863760667819,0.7986911367193057,0.25521021083761947,"['PRKCG', 'PRKCD', 'FGF1']",0.9910724586638838,0,0,3
192,Amyotrophic lateral sclerosis (ALS) WP2447,0.7537031098814176,0.7325793031721269,0.20714173701305075,['TOMM40'],0.9910724586638838,0,0,1
193,The influence of laminopathies on Wnt signaling WP4844,0.7537031098814176,0.7325793031721269,0.20714173701305075,['ZMPSTE24'],0.9910724586638838,0,0,1
194,Cardiac Progenitor Differentiation WP2406,0.7537031098814176,0.7325793031721269,0.20714173701305075,['SOX2'],0.9910724586638838,0,0,1
195,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7537031098814176,0.7325793031721269,0.20714173701305075,['IRF3'],0.9910724586638838,0,0,1
196,Folate Metabolism WP176,0.7537031098814176,0.7325793031721269,0.20714173701305075,['GPX4'],0.9910724586638838,0,0,1
197,Gastric Cancer Network 2 WP2363,0.7537031098814176,0.7325793031721269,0.20714173701305075,['OTUD5'],0.9910724586638838,0,0,1
198,Genes controlling nephrogenesis WP4823,0.7537031098814176,0.7325793031721269,0.20714173701305075,['ROBO2'],0.9910724586638838,0,0,1
199,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7537031098814176,0.7325793031721269,0.20714173701305075,['DDIT3'],0.9910724586638838,0,0,1
200,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7537031098814176,0.7325793031721269,0.20714173701305075,['RABAC1'],0.9910724586638838,0,0,1
201,Netrin-UNC5B signaling pathway WP4747,0.7537031098814176,0.7325793031721269,0.20714173701305075,['DAPK1'],0.9910724586638838,0,0,1
202,Non-small cell lung cancer WP4255,0.7599669181122601,0.7321614583333333,0.20096395197249162,"['PRKCG', 'CYCS']",0.9910724586638838,0,0,2
203,Ebola Virus Pathway on Host WP4217,0.7756524988405192,0.7317423056859677,0.18589962293073806,"['IRF3', 'HLA-B', 'EIF2S1']",0.9910724586638838,0,0,3
204,Pathways Regulating Hippo Signaling WP4540,0.7756524988405192,0.7317423056859677,0.18589962293073806,"['PRKCG', 'PRKCD', 'CDH11']",0.9910724586638838,0,0,3
205,22q11.2 copy number variation syndrome WP4657,0.7783439057867583,0.70275,0.17609988367031165,"['RANBP1', 'MRPL40']",0.9910724586638838,0,0,2
206,Oncostatin M Signaling Pathway WP2374,0.7783439057867583,0.70275,0.17609988367031165,"['PRKCD', 'RPS6']",0.9910724586638838,0,0,2
207,Bladder cancer WP2828,0.7788977717378283,0.6761070442817713,0.16894256670502258,['DAPK1'],0.9910724586638838,0,0,1
208,Vitamin D-sensitive calcium signaling in depression WP4698,0.7788977717378283,0.6761070442817713,0.16894256670502258,['GPX4'],0.9910724586638838,0,0,1
209,Differentiation Pathway WP2848,0.7788977717378283,0.6761070442817713,0.16894256670502258,['FGF1'],0.9910724586638838,0,0,1
210,IL-5 signaling pathway WP127,0.7788977717378283,0.6761070442817713,0.16894256670502258,['RPS6'],0.9910724586638838,0,0,1
211,Lung fibrosis WP3624,0.7788977717378283,0.6761070442817713,0.16894256670502258,['FGF1'],0.9910724586638838,0,0,1
212,Nuclear receptors WP170,0.7788977717378283,0.6761070442817713,0.16894256670502258,['PPARA'],0.9910724586638838,0,0,1
213,Oxidative Damage WP3941,0.7788977717378283,0.6761070442817713,0.16894256670502258,['CYCS'],0.9910724586638838,0,0,1
214,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7919709055948297,0.7313218390804598,0.1705666482903593,"['SOX2', 'SST', 'NGF', 'SLC25A4']",0.9910724586638838,0,0,4
215,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7954772620810424,0.6756009615384615,0.15458629280590946,"['RPS6', 'ZNF516']",0.9910724586638838,0,0,2
216,Joubert Syndrome WP4656,0.7954772620810424,0.6756009615384615,0.15458629280590946,"['CEP120', 'DVL3']",0.9910724586638838,0,0,2
217,Circadian rhythm related genes WP3594,0.7963646003622805,0.7434212276827289,0.16927564367839762,"['PRKCG', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.9910724586638838,0,0,5
218,Type 2 papillary renal cell carcinoma WP4241,0.801518758733367,0.6277022509471808,0.1388771788230609,['ELOB'],0.9910724586638838,0,0,1
219,Interleukin-11 Signaling Pathway WP2332,0.801518758733367,0.6277022509471808,0.1388771788230609,['RPS6'],0.9910724586638838,0,0,1
220,Prader-Willi and Angelman Syndrome WP3998,0.801518758733367,0.6277022509471808,0.1388771788230609,['NGF'],0.9910724586638838,0,0,1
221,Apoptosis WP254,0.811428945381789,0.6504629629629629,0.13591973607761665,"['IRF3', 'CYCS']",0.9910724586638838,0,0,2
222,NO/cGMP/PKG mediated Neuroprotection WP4008,0.821828607112261,0.5857514300572023,0.11493814467546559,['CYCS'],0.9910724586638838,0,0,1
223,p38 MAPK Signaling Pathway WP400,0.821828607112261,0.5857514300572023,0.11493814467546559,['DDIT3'],0.9910724586638838,0,0,1
224,Pathogenic Escherichia coli infection WP2272,0.821828607112261,0.5857514300572023,0.11493814467546559,['ARPC3'],0.9910724586638838,0,0,1
225,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.821828607112261,0.5857514300572023,0.11493814467546559,['IRF3'],0.9910724586638838,0,0,1
226,Apoptosis Modulation and Signaling WP1772,0.8262612413697504,0.6271205357142857,0.11968236875474951,"['ENDOG', 'CYCS']",0.9910724586638838,0,0,2
227,Corticotropin-releasing hormone signaling pathway WP2355,0.8262612413697504,0.6271205357142857,0.11968236875474951,"['PRKCD', 'CRH']",0.9910724586638838,0,0,2
228,ErbB signaling pathway WP673,0.8262612413697504,0.6271205357142857,0.11968236875474951,"['PRKCG', 'ERBB4']",0.9910724586638838,0,0,2
229,Senescence and Autophagy in Cancer WP615,0.8296760576514617,0.6580985915492957,0.12288013371461362,"['GABARAPL1', 'MAP1LC3A', 'SQSTM1']",0.9910724586638838,0,0,3
230,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8312052725244472,0.7454191556480301,0.13781197234788187,"['COL5A1', 'PIK3IP1', 'PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.9910724586638838,0,0,8
231,Copper homeostasis WP3286,0.8400631097637874,0.5490444617784711,0.09568651307473476,['ATOX1'],0.9910724586638838,0,0,1
232,G13 Signaling Pathway WP524,0.8400631097637874,0.5490444617784711,0.09568651307473476,['ARHGDIG'],0.9910724586638838,0,0,1
233,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8400631097637874,0.5490444617784711,0.09568651307473476,['MAP1LC3A'],0.9910724586638838,0,0,1
234,Photodynamic therapy-induced unfolded protein response WP3613,0.8400631097637874,0.5490444617784711,0.09568651307473476,['DDIT3'],0.9910724586638838,0,0,1
235,Glioblastoma signaling pathways WP2261,0.8528143243736557,0.5851041666666666,0.09315644060251718,"['PRKCG', 'PRKCD']",0.9910724586638838,0,0,2
236,Myometrial relaxation and contraction pathways WP289,0.8555924671619674,0.6740731795676851,0.10512919859087705,"['PRKCG', 'GSTO1', 'PRKCD', 'LPAR1', 'CRH']",0.9910724586638838,0,0,5
237,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8564340368013912,0.5166559603560613,0.08007029657941157,['CHP1'],0.9910724586638838,0,0,1
238,ATM Signaling Network in Development and Disease  WP3878,0.8564340368013912,0.5166559603560613,0.08007029657941157,['DCLRE1C'],0.9910724586638838,0,0,1
239,Ectoderm Differentiation WP2858,0.8571002519982239,0.6493672355741321,0.10013267907267491,"['SOX2', 'ARHGDIG', 'DMD', 'MZF1']",0.9910724586638838,0,0,4
240,Regulation of Actin Cytoskeleton WP51,0.8625087612188782,0.6118571896495251,0.09049977990732119,"['TMSB4X', 'BRK1', 'FGF1']",0.9910724586638838,0,0,3
241,Wnt signaling WP428,0.864655602954396,0.5661290322580645,0.08232874737106459,"['PRKCG', 'DVL3']",0.9910724586638838,0,0,2
242,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8711315792587939,0.48786618131391923,0.06730711443952142,['ZMPSTE24'],0.9910724586638838,0,0,1
243,Common Pathways Underlying Drug Addiction WP2636,0.8711315792587939,0.48786618131391923,0.06730711443952142,['PRKCG'],0.9910724586638838,0,0,1
244,Kit receptor signaling pathway WP304,0.8711315792587939,0.48786618131391923,0.06730711443952142,['RPS6'],0.9910724586638838,0,0,1
245,Nephrotic syndrome WP4758,0.8711315792587939,0.48786618131391923,0.06730711443952142,['ZMPSTE24'],0.9910724586638838,0,0,1
246,PPAR signaling pathway WP3942,0.8711315792587939,0.48786618131391923,0.06730711443952142,['PPARA'],0.9910724586638838,0,0,1
247,Mesodermal commitment pathway WP2857,0.8721482091978607,0.5978446436192915,0.0817826989770928,"['SOX2', 'ARL4A', 'RPL38']",0.9910724586638838,0,0,3
248,Spinal Cord Injury WP2431,0.8756176788955283,0.54833984375,0.07283363615753327,"['EFNB2', 'OMG']",0.9910724586638838,0,0,2
249,Fragile X Syndrome  WP4549,0.8825811237138097,0.6148600340977837,0.07679882786871717,"['DUSP3', 'ALDH5A1', 'AP2S1', 'AP2M1']",0.9910724586638838,0,0,4
250,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8843265453402,0.46210690532884474,0.05680628864361107,['MAP1LC3A'],0.9910724586638838,0,0,1
251,"GPCRs, Other WP117",0.8843265453402,0.46210690532884474,0.05680628864361107,['GPR61'],0.9910724586638838,0,0,1
252,Interferon type I signaling pathways WP585,0.8843265453402,0.46210690532884474,0.05680628864361107,['RPS6'],0.9910724586638838,0,0,1
253,Notch Signaling Pathway Netpath WP61,0.8843265453402,0.46210690532884474,0.05680628864361107,['APH1A'],0.9910724586638838,0,0,1
254,Thermogenesis WP4321,0.8857563284154011,0.5316287878787879,0.06449369077955887,"['RPS6', 'ZNF516']",0.9910724586638838,0,0,2
255,ESC Pluripotency Pathways WP3931,0.8857563284154011,0.5316287878787879,0.06449369077955887,"['DVL3', 'FGF1']",0.9910724586638838,0,0,2
256,Endoderm differentiation WP2853,0.8896500179031288,0.5716472749540723,0.06684107632197618,"['SOX2', 'DUSP4', 'TCEAL2']",0.9910724586638838,0,0,3
257,Proximal tubule transport WP4917,0.8961723326388623,0.4389235569422777,0.048115919113617414,['ATP6V1F'],0.9910724586638838,0,0,1
258,RANKL/RANK signaling pathway WP2018,0.8961723326388623,0.4389235569422777,0.048115919113617414,['SQSTM1'],0.9910724586638838,0,0,1
259,Rett syndrome causing genes WP4312,0.8961723326388623,0.4389235569422777,0.048115919113617414,['GPS2'],0.9910724586638838,0,0,1
260,Androgen receptor signaling pathway WP138,0.9037752900208651,0.5010714285714286,0.05069566251163773,"['SUMO1', 'PARK7']",0.9910724586638838,0,0,2
261,G Protein Signaling Pathways WP35,0.9037752900208651,0.5010714285714286,0.05069566251163773,"['PRKCG', 'PRKCD']",0.9910724586638838,0,0,2
262,Integrated breast cancer pathway WP1984,0.9049771802281777,0.547633020344288,0.05467872056218303,"['FER', 'ODC1', 'FAU']",0.9910724586638838,0,0,3
263,DNA damage response WP707,0.906806700388513,0.41794814649728845,0.04088618339595877,['CYCS'],0.9910724586638838,0,0,1
264,IL-1 signaling pathway WP195,0.906806700388513,0.41794814649728845,0.04088618339595877,['SQSTM1'],0.9910724586638838,0,0,1
265,MET in type 1 papillary renal cell carcinoma WP4205,0.906806700388513,0.41794814649728845,0.04088618339595877,['RPL11'],0.9910724586638838,0,0,1
266,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.906806700388513,0.41794814649728845,0.04088618339595877,['ANGPTL1'],0.9910724586638838,0,0,1
267,Focal Adhesion WP306,0.9103545445594953,0.5741302225191428,0.053922968419644876,"['PRKCG', 'PDGFC', 'VEGFB', 'TLN1']",0.9910724586638838,0,0,4
268,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9163533615456535,0.39887959154729824,0.03484341783758465,['DCLRE1C'],0.9910724586638838,0,0,1
269,miRNA regulation of DNA damage response WP1530,0.9163533615456535,0.39887959154729824,0.03484341783758465,['CYCS'],0.9910724586638838,0,0,1
270,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9163533615456535,0.39887959154729824,0.03484341783758465,['DVL3'],0.9910724586638838,0,0,1
271,Prolactin Signaling Pathway WP2037,0.9163533615456535,0.39887959154729824,0.03484341783758465,['RPS6'],0.9910724586638838,0,0,1
272,DNA damage response (only ATM dependent) WP710,0.9191125470781861,0.47381756756756754,0.03996494691296645,"['BCL6', 'DVL3']",0.9910724586638838,0,0,2
273,Insulin Signaling WP481,0.9243779994984239,0.5151431464604621,0.04050786953134544,"['PRKCD', 'ENPP1', 'STX4']",0.9910724586638838,0,0,3
274,Endometrial cancer WP4155,0.9249234129950862,0.38146917181035067,0.02977151037738004,['FGF1'],0.9910724586638838,0,0,1
275,Neural Crest Differentiation WP2064,0.9249234129950862,0.38146917181035067,0.02977151037738004,['DVL3'],0.9910724586638838,0,0,1
276,TGF-beta Signaling Pathway WP366,0.9321290712993722,0.4493589743589744,0.03158273957817669,"['PARD6A', 'SUMO1']",0.9910724586638838,0,0,2
277,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9326166202453887,0.3655096203848154,0.025498343440868692,['TLN1'],0.9910724586638838,0,0,1
278,Hepatitis B infection WP4666,0.9352214459628502,0.4955266188324918,0.03318637756456372,"['PRKCG', 'IRF3', 'CYCS']",0.9910724586638838,0,0,3
279,Nuclear Receptors Meta-Pathway WP2882,0.9367112492903522,0.5824947589098532,0.03808362928165301,"['PSMC5', 'GSTP1', 'BLVRB', 'PPARA', 'SQSTM1', 'CES2']",0.9910724586638838,0,0,6
280,PI3K-Akt signaling pathway WP4172,0.9367112492903522,0.5824947589098532,0.03808362928165301,"['PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.9910724586638838,0,0,6
281,T-cell receptor (TCR) signaling pathway WP69,0.9395225716724174,0.3508268330733229,0.021885783014604976,['PRKCD'],0.9910724586638838,0,0,1
282,Toll-like Receptor Signaling Pathway WP75,0.9395225716724174,0.3508268330733229,0.021885783014604976,['IRF3'],0.9910724586638838,0,0,1
283,Breast cancer pathway WP4262,0.9431468554595968,0.4272865853658537,0.02501048375152347,"['DVL3', 'FGF1']",0.9910724586638838,0,0,2
284,Vitamin D Receptor Pathway WP2877,0.9431468554595968,0.4272865853658537,0.02501048375152347,"['BCL6', 'CLPTM1L']",0.9910724586638838,0,0,2
285,Gastrin signaling pathway WP4659,0.9431468554595968,0.4272865853658537,0.02501048375152347,"['RPS6', 'PRKCD']",0.9910724586638838,0,0,2
286,Chemokine signaling pathway WP3929,0.9479965416245744,0.41703869047619047,0.02227171138802666,"['PRKCD', 'RASGRP2']",0.9910724586638838,0,0,2
287,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9512862885191539,0.3247241000751141,0.0162167937399289,['DMD'],0.9910724586638838,0,0,1
288,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9512862885191539,0.3247241000751141,0.0162167937399289,['RPS6'],0.9910724586638838,0,0,1
289,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9512862885191539,0.3247241000751141,0.0162167937399289,['DVL3'],0.9910724586638838,0,0,1
290,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9562811585181327,0.3130710942723423,0.013995314273527303,['CYCS'],0.9910724586638838,0,0,1
291,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9562811585181327,0.3130710942723423,0.013995314273527303,['ENPP1'],0.9910724586638838,0,0,1
292,Endochondral Ossification WP474,0.9562811585181327,0.3130710942723423,0.013995314273527303,['ENPP1'],0.9910724586638838,0,0,1
293,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9562811585181327,0.3130710942723423,0.013995314273527303,['EIF2B5'],0.9910724586638838,0,0,1
294,Head and Neck Squamous Cell Carcinoma WP4674,0.9607645694015746,0.3022217440421755,0.012096692783483019,['RPS6'],0.9910724586638838,0,0,1
295,Melanoma WP4685,0.9607645694015746,0.3022217440421755,0.012096692783483019,['ERBB4'],0.9910724586638838,0,0,1
296,DNA IR-damage and cellular response via ATR WP4016,0.964788819332182,0.29209568382735307,0.010470474051885765,['BCL6'],0.9910724586638838,0,0,1
297,Leptin signaling pathway WP2034,0.964788819332182,0.29209568382735307,0.010470474051885765,['RPS6'],0.9910724586638838,0,0,1
298,Small cell lung cancer WP4658,0.9684008664722263,0.2826229178199386,0.009074784254056289,['CYCS'],0.9910724586638838,0,0,1
299,Integrin-mediated Cell Adhesion WP185,0.9684008664722263,0.2826229178199386,0.009074784254056289,['TLN1'],0.9910724586638838,0,0,1
300,Calcium Regulation in the Cardiac Cell WP536,0.9772842713392416,0.3969981505192773,0.009122106690407776,"['PRKCG', 'PRKCD', 'ATP1B2']",0.9932064275058389,0,0,3
301,Pancreatic adenocarcinoma pathway WP4263,0.9795082680624052,0.25014486293737465,0.005179149461276825,['PRKCD'],0.9932064275058389,0,0,1
302,"GPCRs, Class A Rhodopsin-like WP455",0.9834999096991003,0.23653919129738163,0.003935475901482774,['MCHR1'],0.9932064275058389,0,0,1
303,Genes related to primary cilium development (based on CRISPR) WP4536,0.986714882228023,0.22432897315892636,0.003000210324117122,['CEP120'],0.9932064275058389,0,0,1
304,Hippo-Merlin Signaling Dysregulation WP4541,0.986714882228023,0.22432897315892636,0.003000210324117122,['CDH11'],0.9932064275058389,0,0,1
305,Ras signaling WP4223,0.9918073325708499,0.28150201612903225,0.002315751495774128,"['PRKCG', 'RASGRP2']",0.9950591598907542,0,0,2
306,Ciliopathies WP4803,0.996857546163975,0.2419704861111111,0.0007615783223481288,"['CEP120', 'PKD1L1']",0.996857546163975,0,0,2
